about
The X-factor in primary biliary cirrhosis: monosomy X and xenobioticsMuscle biopsy features of idiopathic inflammatory myopathies and differential diagnosisThe immunofluorescence techniques in the diagnosis of endocrine autoimmune diseasesInfections as a cause of autoimmune rheumatic diseasesManagement of the antiphospholipid syndromeFetomaternal alloimmunity as a cause of liver disease.Autoimmunity in connection with a metal implant: a case of autoimmune/autoinflammatory syndrome induced by adjuvants.A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage.Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methodsChemiluminescent immunoassay technology: what does it change in autoantibody detection?Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory.Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disordersDrugs in induction and treatment of idiopathic inflammatory myopathiesMyositis autoantibodies and clinical phenotypes.Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.Treatment of the antiphospholipid syndrome.A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3).Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host diseasePathophysiology of the antiphospholipid antibody syndrome.In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70).Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodiesNatural killer cells in patients with severe chronic fatigue syndrome.Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients.Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa.StreptInCor: a model of anti-Streptococcus pyogenes vaccine reviewed.Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideDiagnostic sensitivity of thyroid autoantibodies assessed in a population-based, cross-sectional study in adults.Protective molecules and their cognate antibodies: new players in autoimmunityArterial occlusion mimicking vasculitis in a patient with incontinentia pigmentiDetection of autoantibodies in a point-of-care rheumatology setting.Characterization for anti-cytoplasmic antibodies specificity by morphological and molecular techniquesMissing links in high quality diagnostics of inflammatory systemic rheumatic diseases: It is all about the patient!Pearls in autoimmunityMyositis-specific autoantibodies: detection and clinical associations.The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Popular and unpopular infectious agents linked to primary biliary cirrhosis.
P1433
Q26830032-52FC500B-9838-4E6C-9B22-768D9E39F255Q26991722-F3EB96DB-32A9-474D-9A56-78219294D40DQ27021361-A0DAEE29-342D-406B-A5CF-27F8C4916B57Q28074204-3AC501FC-AE5F-4EE0-ACEF-723E97559B12Q33423034-F2205B58-447F-47A7-BAC8-5D455BCBA19CQ33423039-212D83D7-B79B-459C-80C0-FEAB7302B615Q33423042-68DDE672-405C-4974-98D3-04C173A44A4BQ33612412-1D448AFF-8777-49B7-BE6E-14BE5A12A4BFQ33812382-48E1E43A-920C-41D1-851B-FBE29F1419AFQ33830773-77384C17-0A21-4E83-B7F1-CC043892C99CQ34477430-37BAC629-5F0A-4858-B9EF-ECC4501C8CBAQ34477437-46CDB7FA-3DCF-4740-A37C-0065A66DBD04Q35281940-BB0640F8-C750-4E30-B375-566C7049CACCQ35281962-68A42EDD-929F-4169-8981-2ECD65E406BBQ35281980-2D764CA2-DD05-423A-8F22-6790B2715605Q35308947-35465D60-F0B0-4B71-8260-7316134837E6Q35308972-8693982A-CD48-4E8A-9C56-49DFE8E298EDQ35308989-102A6D28-A62C-4F4C-8900-570FC826F93CQ35309009-56E468F7-AE62-4B60-9169-1B7F515EED6DQ35309024-F12F151C-FC31-4867-BEA0-01C98239F0BAQ35309042-F625E079-5B04-438C-9446-6A85B6F5E9A7Q35309080-7C2935E7-4B32-465A-8F66-DC1D95C09455Q35309103-D822732D-B5FB-4824-85E5-9015346C1061Q35309120-A33CEFB9-6F42-46D2-9477-FA9E6E162D09Q35309145-ED4F7A62-8848-429D-8E7E-E67C5CF59529Q35309163-3538ED58-A7ED-461A-A9D0-186E481C3844Q35309185-58A8C348-A0F2-4CE1-A18C-06A43B409E25Q35309203-CCF63594-63F8-4ED9-9404-F73BCADA9558Q35309470-4BF83DCA-0332-425D-9C4C-CA7B913AA1EAQ35309493-AED769B4-A9D2-46FB-BDB9-1514769ADD42Q35309510-B548C4BB-4C14-4860-ACAE-1FD74776196AQ35309533-9B4061D2-B689-427A-9082-49314B5DCE39Q35309576-E5F7747C-1C7A-474E-92C6-39CBB935B89CQ35309699-44ECF188-95CF-4269-A271-C357522E0244Q35309739-921EAFB8-55B7-4A8A-B81A-7C6692E1BD71Q35309787-267A3980-2DE8-4AB1-A0C9-BA82C884A325Q35309808-6759BB30-394D-429B-8C3E-8FA8CFC700A0Q35309836-0064CB48-FC17-469D-8FF1-E83240993966Q35309854-5ED445D4-5F3E-4776-8612-C051BB8C2373Q35309882-A66689B9-E8E9-4210-9C1C-78C5A9AD2BD7
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Autoimmunity highlights
@ast
Autoimmunity highlights
@en
Autoimmunity highlights
@es
Autoimmunity highlights
@it
Autoimmunity highlights
@nl
type
label
Autoimmunity highlights
@ast
Autoimmunity highlights
@en
Autoimmunity highlights
@es
Autoimmunity highlights
@it
Autoimmunity highlights
@nl
prefLabel
Autoimmunity highlights
@ast
Autoimmunity highlights
@en
Autoimmunity highlights
@es
Autoimmunity highlights
@it
Autoimmunity highlights
@nl
P3181
P1055
P1156
19700202609